Laboratory identification of lupus anticoagulants

Seminars in Thrombosis and Hemostasis
Geoffrey KershawYun-Mi Nguy

Abstract

The main laboratory characteristic of lupus anticoagulants (LA) is their ability to prolong phospholipid-dependent clotting time in vitro. The laboratory demonstration of LA requires a systematic approach combined with an awareness of the many variables that can affect test results. The ideal testing procedures are those sensitive enough to detect weak LA and specific enough so as not to produce incorrect conclusions. International guidelines have been published to assist laboratories in applying correct testing processes. The most recently published guidelines from the International Society on Thrombosis and Haemostasis update the criteria for detecting the presence of LA that were presented in the 1995 guidelines. Some of the specific recommendations relate to the key areas of setting cut-off levels for screening, mixing, and confirmatory procedures. The more challenging aspects of testing for LA include maintaining sensitivity and specificity of the assays, especially in the presence of anticoagulant therapy.

Citations

Aug 6, 2013·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Emmanuel J FavaloroKatherine Marsden
Jul 4, 2013·Southern Medical Journal·Pramod Reddy
Oct 25, 2012·Biochemia Medica·Emmanuel J Favaloro, Giuseppe Lippi
Jan 21, 2016·Expert Review of Hematology·Cecilia Beatrice ChighizolaPier Luigi Meroni
Apr 18, 2013·International Journal of Laboratory Hematology·E J Favaloro
Apr 23, 2014·International Journal of Laboratory Hematology·G W Moore
Sep 14, 2017·Biochemia Medica·Franz RatzingerPeter Quehenberger
Jan 17, 2016·The Journal of Rheumatology·Andrea Hinojosa-AzaolaJorge Sanchez-Guerrero
Dec 3, 2015·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Vani Chandrashekar
Mar 26, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Giuseppe Lippi, Mario Plebani
Oct 18, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Emmanuel J Favaloro
Oct 25, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Giuseppe Lippi, Emmanuel J Favaloro
Apr 9, 2017·International Journal of Hematology·Kazunori KanouchiAkira Fukao
Dec 2, 2016·Antibodies·Gary W Moore
Sep 15, 2015·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Alessandra PozRoberta Giacomello
Dec 6, 2018·Clinical Rheumatology·María Del Carmen Zamora-MedinaJuanita Romero-Diaz
Aug 2, 2017·The American Journal of the Medical Sciences·Ke YaoDengju Li
Jul 15, 2021·Seminars in Thrombosis and Hemostasis·Gábor SzabóJános Kappelmayer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.